Northwire Canada EditionMonday, July 13, 2026
Northwire
GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0% GLDN 0.055 +0.0% BRON 0.040 +0.0% BTO 5.43 −0.7% ESK 0.365 −2.7% AUMN 0.275 +0.0% GGX 0.040 +0.0% S 0.155 +29.2% NNX 0.035 +0.0% ABX 51.90 −0.6% TTS 2.40 −4.0% FCI 0.400 −9.1% GR 0.075 +0.0% AII 23.38 +12.4% TUNG 1.72 +1.8% LGO 1.01 −2.9% EMM 0.080 +0.0%
Production / Operations

Herbal Dispatch ships 298 kg medical pot to Germany

HERB · Price

Executive Summary

  • Herbal Dispatch Inc. completed its first export of 298 kg of medical cannabis to a EU‑GMP licensed processor in Portugal for onward shipment to Germany.
  • The new export relationship is expected to generate recurring revenue streams and support growth throughout 2026 and beyond.
  • The partnership gives the company access to Europe’s largest medical‑cannabis market, which recorded record imports of >140 t in the first nine months of 2025.

Key Details

  • Export quantity: 298 kg of medical cannabis.
  • Route: Shipped from Canada → processed in Portugal (EU‑GMP licensed processor) → destined for the German medical‑cannabis market.
  • This is Herbal Dispatch’s inaugural shipment to a EU‑GMP partner in Portugal, establishing a new export channel.
  • Company anticipates multiple follow‑on exports to the same Portuguese partner over upcoming quarters.
  • Germany imported >140 t of medical cannabis in the first nine months of 2025 (≈57 t in Q3 2025), with an annual import quota of ~192.5 t, indicating strong market demand.
  • Management view: CEO Philip Campbell states the export “marks a key step in expanding our international footprint” and expects it to “drive meaningful growth … in 2026 and beyond.”

Notable Quotes

“We are thrilled to achieve this milestone with our first export to our Portuguese partner, marking a key step in expanding our international footprint,” said Philip Campbell, CEO.
“Germany represents the most dynamic and largest medical cannabis opportunity in Europe… we anticipate building a robust, recurring revenue stream that will drive meaningful growth for the company and deliver value to our shareholders in 2026 and beyond.”

Read the original news release →

More from Herbal Dispatch Inc